Intellia, expanding in gene editing, buys startup Rewrite for $45M
Bio Pharma Dive
FEBRUARY 3, 2022
Founded by University of California, Berkeley scientists, Rewrite is studying ways to expand the reach of gene editing beyond limitations of current technologies, including Intellia's.
Let's personalize your content